FDA Approves the First Oral GLP-1 Drug for Obesity
JAMA Medical News
00:00
Which formulation might clinicians prefer
Kate reports clinicians' view that choice depends on preference, coverage, and that many still favor injections now.
Play episode from 03:39
Transcript
